Cholangiocarcinoma in HIV-infected patients with a history of cholangitis [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 2, 2005, Pages 253-255

  Charlier, Caroline ^a   Lecuit, Marc ^a   Furco, André ^b   Estavoyer, Jean Marie ^c   Lafeuillade, Alain ^d   Dupont, Bertrand ^a   Lortholary, Olivier ^a   Viard, Jean Paul ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d Hopital Chalucet Toulon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOKERATIN 7; FLUOROURACIT; GEMCITABINE; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; BILE DUCT CARCINOMA; CANCER SURGERY; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETTER; LIVER BIOPSY; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; PRIORITY JOURNAL; RADIODIAGNOSIS; SPHINCTEROTOMY; TREATMENT OUTCOME;

ADULT; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CHOLANGITIS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED;

EID: 19644396057     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. Levine AM, Hodgkin's disease in the settings of human immunodeficiency virus infection. J Natl Cancer Inst Monogr. 1998;23:37-42.
2. Sutton L, Guénel P, Tanguy ML, et al. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol. 2001;112:900-908.
3. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;15:3447-3453.
4. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis, 2004;24:115-125.
5. Hocqueloux L, Gervais A. Cholangiocarcinoma and AIDS-related sclerosing cholangitis. Ann Intern Med. 2000;132:1006-1007.
6. De Groen PC, Gores GJ, LaRusso MF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368-1378.
7. Shimonishi T, Sasaki M, Nakasuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2000;7:542-550.
8. Martelius T, Krogerus L, Hockerstedt K, et al. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology. 1998;27:996-1002.
9. Mansfield KG, Carville A, Shvetz D, et al. Identification of an Enterocytozoon bieneusilike microsporidian parasite in simian-immunodeficiency- virus-inoculated macaques with hepatobiliary disease. Am J Pathol. 1997;150:1395-1405.
10. Stephens J, Cosyns M, Jones M, et al. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatohgy. 1999;30:27-35.
11. Hayward AR, Levy J, Facchetri F, et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree with X-linked immunodeficiency with hyper-IgM. J Immunol. 1997;158:977-983.
12. Matthews GV, Bower M, Mandalia S, et al, Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood. 2000;96:2730-2734.
13. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004;24:189-199.
14. Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis. 2004;24:139-154.